Please Wait...

Bioclinica

Translation skills

Main profile

BioClinica accelerates the development of new medical therapies by delivering expertise and technologies that enhance clinical research, worldwide. Our industry-leading Medical Imaging services, Cardiac Safety, and enterprise eClinical platform bring a new level of quality and efficiency to every phase of clinical development. Our experience spans three decades and includes thousands of studies in all therapeutic areas, from design and management, through submission and post-approval. BioClinica serves more than 400 pharmaceutical, biotechnology, and device companies – including all the top 20 – through a network of offices in the U.S., Europe, and Asia.

Blogs

A special guest blog post by Jennifer Price, Senior Director of Clinical Data Management, Paidion Research

Site selection is becoming increasingly challenging – sites are saturated with studies, clinics are asked to divide their time between standard patient care and clinical trial responsibilities, and study protocols are ever-more complex. Finding and selecting sites again and again, for each new study, sacrifices your valuable resources.

Presenting at the DIA’s 21st Annual Workshop in Japan for Clinical Data Management, I had the opportunity to compare academic studies in the US vs those in Japan as well as the differences in data management practices between academic and industry studies.

Latin America: Benefit from the Right Partner

Latin America is a geographical region with a largely untapped population for clinical trials, and it has experienced tenfold growth in clinical trials since 2000.1 However, according to clinicaltrials.gov, there are currently only approximately 3,500 studies being conducted in all of Latin America, compared with the approximate 30,000 in the United States alone.

As an industry, we assign considerable resources and money to the recruitment and enrollment of patients, but tend to focus less effort on finding patients that drop out of the trial. We know that lost patients compromise the integrity of our data, and therefore regulatory submissions. However, replacing lost patients with new patients costs money and takes time.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

RT @SullyHIT: .@HIMSS writes new definition of interoperability - and seeks feedback https://t.co/p1fi4nqrsG @HealthITNews "This definition…
Bioclinica (2 days ago)
RT @DellEMCHealth: Top pharma use cases for the cloud https://t.co/mtPsdmfwXn via @HealthITNews #TransformHIT https://t.co/w14VstRwf0
Bioclinica (2 days ago)
RT @DDNewsOnline: Look into recent efforts to understand & fight #glioblastoma & #medulloblastoma Read our Spotlight on #Oncology “#Cancer…
Bioclinica (2 days ago)
Sponsors conducting clinical trials in #NAFLD or #NASH are invited to join us in an upcoming webinar exploring the… https://t.co/I19Bz8WLBa
Bioclinica (2 days ago)
RT @RAPSorg: Reorganization of @US_FDA’s Office of the Commissioner to Begin Soon | #Regulatory Focus https://t.co/9b3UshJUgD #FDA
Bioclinica (2 days ago)
RT @ACROhealth: More than 325 million people own wearable devices, making it more convenient than ever for researchers to incorporate them…
Bioclinica (2 days ago)

Latest Blogs:

Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box